Abstract:
PURPOSE: A soft coral extract is provided to ensure antioxidation, anti-inflammation, and whitening activities. CONSTITUTION: A pharmaceutical composition for antioxidation or anti-inflammation contains Alcyonium gracillimum extract or Dendronephtya gigantean extract as an active ingredient. A food composition for antioxidation contains Alcyonium gracillimum extract or Dendronephtya gigantean extract as an active ingredient. The extract is an ethyl acetate layer fraction obtained by extracting Alcyonium gracillimum or Dendronephtya gigantean with water, ethanol, or mixture solvent thereof and fractioning with water and ethyl acetate.
Abstract:
PURPOSE: A composition for skin whitening using acanthoic acid is provided to suppress melanogenesis, TRP-1 and TRP-2 and to inhibit MIFT activation. CONSTITUTION: A cosmetic composition for skin whitening contains Acanthopanax koreanum root bark extract as an active ingredient. A soap composition for skin whitening contains the extract as an active ingredient. A pharmaceutical composition for skin whitening contains the extract as an active ingredient. The extract is a crude extract prepared by dipping Acanthopanax koreanum root bark with water, methanol, ethanol, butanol, acetone, ethyl acetate, chloroform, methylene chloride, or a mixture solvent thereof. The extract is also prepared by fractioning the crude extract with a solvent.
Abstract:
PURPOSE: A skin whitening composition is provided to produce a cosmetic product and soap for whitening. CONSTITUTION: A skin whitening composition contains Stichopus japonicus extract obtained by isolating Stichopus japonicus using methanol and distilled water or fraction thereof as an active ingredient. The fraction is isolated using water, distilled water, ethanol, or mixture solvent thereof. The fraction is an ethylacetate fraction of solid extract of Stichopus japonicus. The composition is a cosmetic composition or pharmaceutical composition. The pharmaceutical composition has pharmacological effects of preventing or treating melasma, fleck, or skin aging.
Abstract:
PURPOSE: A skin whitening composition is provided to produce a cosmetic product and soap for whitening. CONSTITUTION: A skin whitening composition contains Stichopus japonicus extract obtained by isolating Stichopus japonicus using methanol and distilled water or fraction thereof as an active ingredient. The fraction is isolated using water, distilled water, ethanol, or mixture solvent thereof. The fraction is an ethylacetate fraction of solid extract of Stichopus japonicus. The composition is a cosmetic composition or pharmaceutical composition. The pharmaceutical composition has pharmacological effects of preventing or treating melasma, fleck, or skin aging.
Abstract:
PURPOSE: A composition for anti-inflammation using Hypochoeris radicata L. extract is provided to suppress generation of NO, PGE2, and inflammatory cytokines. CONSTITUTION: A composition for anti-inflammation contains Hypochoeris radicata L. extract as an active ingredient. The extract is prepared using water, distilled water, ethanol, or mixture solvent thereof and by fractioning the solid extract into a water layer and an ethyl acetate layer. The composition is a pharmaceutical composition or food composition. A pharmaceutical composition of an iNOS inhibitor or COS-2 inhibitor contains the extract as an active ingredient.
Abstract:
PURPOSE: A skin whitening composition using acanthoic acid is provided to suppress melanogenesis and TRP-1 and TRP-2 generation. CONSTITUTION: A skin whitening composition contains 0.05-15.00 weight% of Acanthopanax Koreanum root bark extract or acanthoic acid as an active ingredient. The skin whitening composition is a cosmetic composition, soap composition, and pharmaceutical composition. The composition additionally contains a skin whitening compounds such as mercaptosuccinic acid, mercaptodextran, dihydroxy-isoquinoline or plant extract such as lemon extract, cucumber extract, mulberry extract, rosemary extract, gingko extract, or herb extract.
Abstract:
PURPOSE: A composition for anti-cancer containing seaweed extract is provided to ensure indication of blood cancer, colon cancer, skin cancer or lung cancer and to apply to a pharmaceutical composition or food composition. CONSTITUTION: A composition for treating blood caner contains seaweed extract or fraction thereof as an active ingredient. The seaweed is Petalonia binghamiae, Sargassum nipponicum Yendo, Dictyopteris divaricata or Myelophycus simplex. The extract isolated using methanol, distilled water, ethanol, acetone, ethyl acetate, saturated normal butanol, chloroform, methylene chloride, water or mixture thereof. The seaweed fraction is obtained by removing extraction solvent from the seaweed extract to obtain solid extract, and fractioning into ethanol layer and ethylacetate layer.
Abstract:
본 발명은 섬오갈피 근피의 주요 성분인 아칸토산을 이용한 피부 미백제 조성물을 개시한다. 본 발명의 피부 미백제 조성물에 유효성분으로 포함되는 아칸토산은 멜라노마 세포인 B16F10에 처리되었을 때 멜라닌 생성을 억제하고, 멜라닌의 생성에 관여하는 주요 효소인 티로시나아제, TRP-1 및 TRP-2의 생성을 억제할 뿐만 아니라, 이들 단백질의 발현을 촉진하는 전사인자인 MIFT의 활성을 저해한다.
Abstract:
PURPOSE: A soft coral extract is provided to ensure antioxidation, anti-inflammation, and whitening activities. CONSTITUTION: A pharmaceutical composition for antioxidation or anti-inflammation contains Alcyonium gracillimum extract or Dendronephtya gigantean extract as an active ingredient. A food composition for antioxidation contains Alcyonium gracillimum extract or Dendronephtya gigantean extract as an active ingredient. The extract is an ethyl acetate layer fraction obtained by extracting Alcyonium gracillimum or Dendronephtya gigantean with water, ethanol, or mixture solvent thereof and fractioning with water and ethyl acetate.